baltic17 - lud€¦ · furthermore special tips & tricks are shown and/or discussed by the...

An application hasbeen made to theEACCME® for CMEaccreditation ofthis event

www.baltic17.org

BALTIC174th Baltic Meetingin conjunction with the EAU

26-27 May 2017, Vilnius, Lithuania

Programme

Abstract bookThe accepted abstracts of the EAU Regional Meetings are going to be published online by Elsevier as an official supplement of European Urology. This supplement will be online as of1 July 2017 at www.sciencedirect.com. The abstracts will also be online at http://baltic2017.uroweb.org/. The abstracts are documented in an international online journal and can be cited, providing proof of the academic productivity of the regions.

AccreditationThe 4th Baltic Meeting in conjunction with the EAU is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The 4th Baltic Meeting in conjunction with the EAU is designated for a maximum of 11 hours of European external CME credits. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found atwww.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Certificate of attendanceDelegates who have attended the meeting can print their certificate of attendance onlinethrough http://baltic2017.uroweb.org/ using the barcode on the badge. This option is available as of Wednesday, 1 June 2017.

ExhibitionThe local organising committee has invited pharmaceutical companies, manufacturers oftechnical equipment and software as well as publishers of scientific books to exhibit theirproducts at the exhibition organised at the meeting venue.

General Information

2 4th Baltic meeting in conjunction with the EAU

08.30 – 08.40 Welcome M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) P. Vaganovs, Riga (LV) C.R. Chapple, Sheffield (GB)

08.40 – 09.10 EAU Lecture Good practice of PSA screening: Lessons from Swedish experience G.M. Ahlgren, Malmö (SE)

09.10 – 10.50 Urogenital cancer Chairs: F. Jankevicius, Vilnius (LT) P. Vaganovs, Riga (LV) 09.10 – 09.30 The role of mpMRI in decision making for screening and focal therapy of

prostate cancer J.P.M. Sedelaar, Nijmegen (NL) 09.30 – 09.50 Is quality of life after surgery for high risk prostate cancer better than after

radiotherapy? S. Joniau, Leuven (BE)09.50 – 10.10 Upper-tract urothealialcancer – Is it the same bladder cancer? A. Ploumidis, Athens (GR) 10.10 – 10.30 Renal mass biopsy: Whom and how A. Volpe, Novara (IT)10.30 - 10.50 Fluorescent cystoscopy-assisted TUR: Does it affect outcome in NMIBC patients? A.I. Rolevich, Minsk (BY)

10.50 – 11.15 Coffee break

11.15 – 12.30 Poster session 1: Diagnosis and management of kidney cancer Room: Lambda Chairs: D. Milonas, Kaunas (LT) A. Volpe, Novara (IT)

Poster session 2: Miscellaneous Room: Theta Chairs: B. Djavan, Vienna (AT) T. Tamm, Tallinn (EE)

Programme Friday, 26 May 2017

326-27 May 2017


12.30 – 13.15 Industry sponsored session See programme page 16

13.15 – 14.15 Lunch


15.00 – 16.00 Young Urologists Competition Chairs: B. Djavan, Vienna (AT) J.P.M. Sedelaar, Nijmegen (NL)

Judges: C.R. Chapple, Sheffield (GB) M. Jievaltas, Kaunas (LT) S. Joniau, Leuven (BE) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) P. Vaganovs, Riga (LV)

15.00 – 15.15 Modern approach to hereditary prostate cancer A. Patasius, Vilnius (LT)15.15 – 15.30 Characteristics and outcomes of patients with urosepsis in an intensive care unit A. Freimanis, Riga (LV)15.30 – 15.45 Management of urethral trauma – to realign or not to realign? R. Okas, Tallinn (EE) 15.45 – 16.00 Importance and limits of warm ischemia during partial nephrectomy L. Suslov, Minsk (BY)



16.00 – 16.45 Urolithiasis and LUTS Chairs: T. Tamm, Tallinn (EE) E. Vjaters, Riga (LV)

16.00 – 16.15 Metabolic evaluation in prevention of urinary stone recurrence: What is the evidence?

M. Kivi, Tallinn (EE)16.15 – 16.30 Large prostates: Knife or laser? Is it open prostatectomy still “gold standard”? A. Gaižauskas, Vilnius (LT) 16.30 – 16.45 Understanding nocturia in older men H. Hashim, Bristol (GB)


17.00 – 18.15 Poster session 3: Advances in diagnosis and management of prostate cancer Room: Lambda Chairs: M. Jievaltas, Kaunasa (LT) S. Joniau, Leuven (BE)

Poster session 4: Miscellaneous Room: Theta Chairs: H. Hashim, Bristol (GB) A. Kotsar, Tartu (EE)

526-27 May 2017


ESU/ ESUT Hands-on Training courses in Laparoscopy

Course Coordinator: J. Klein, Ulm (DE)

Format: Introduction by course coordinator (15 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (25 minutes)

Room: Gamma/Eta room

09.00 – 10.30 Course 1 Chair: J. Klein, Ulm (DE) Tutors: V. Eret, Plzen (CZ) J. Sabalys, Vilnius (LT)


16.30 – 17.30 Course 1 Case discussions, Tips & Tricks and Experience exchange Tutors: J. Klein, Ulm (DE) J. Sabalys, Vilnius (LT)

Course 3 focusses on the technical aspects of interesting clinical cases. Two expert surgeons discuss 1-2 prepared cases, each that show a difficult situation that occurs during surgery (e.g. management of bleeding of the renal pedicle during lap. nephrectomy) and how to manage this situation. The cases are prepared by the tutors of the course and discussed with the participants of the course in an interactive way. Furthermore special tips & tricks are shown and/or discussed by the tutors. This leads to an experience exchange that is beneficial for every participant of the course.

You can register for these courses at the EAU registration desk!

Aims and objectivesLaparoscopic procedures are continuously evolving in urology based on the increasing expertise of urologic surgeons. This includes ablative procedures, such as radical nephrectomy as well as reconstructive techniques, such as pyeloplasty. Some advanced procedures (i.e. radical prostatectomy, radical cystectomy) have both, ablative and reconstructive steps. Since the number of centres with laparoscopic expertise is still limited in Europe, laparoscopic training programmes have become very important. Hands-on training courses at the pelvi-trainer represent one of the main steps of such courses. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks.


Programme Saturday, 27 May 2017

08.30 – 09.30 Reconstructive and functional urology Chairs: A. Kotsar, Tartu (EE) D. Trumbeckas, Kaunas (LT)

08.30 – 08.45 Failed urethral reconstruction C.R. Chapple, Sheffield (GB) 08.45 – 09.00 Modern management of Peyronie’s disease D. Trumbeckas, Kaunas (LT) 09.00 – 09.15 Myths and facts of vasectomy A. Abele, Riga (LV)09.15 – 09.30 Renovascular reconstruction of grafts in kidney transplantation or other J. Kahu, Tartu (EE)


09.45 – 12.15 ESU Course Flexible URS (RIRS: Retrograde intra-renal surgery) Chair: O. Traxer, Paris (FR)

09.45 - 09.50 European School of Urology: A unique possibility for urological education O. Traxer, Paris (FR)09.50 - 10.05 EAU Guidelines recommendations on retrograde intra-renal surgery G. Giusti, Milan (IT)10.05 - 10.30 Flexible Ureterorenoscopes: What do we have in 2017? G. Giusti, Milan (IT)10.30 - 10.50 Holmium YAG Laser: the best partner for RIRS O. Traxer, Paris (FR)10.50 - 11.10 RIRS Technical aspects and Tips and Tricks O. Traxer, Paris (FR)11.10 - 11.25 How to prevent and manage complications in RIRS G. Giusti, Milan (IT)11.25 - 12.15 Interactive case discussion Local + ESU faculty


13.15 – 14.15 Lunch

726-27 May 2017


14.15 – 15.30 Poster session 5: Advances in the management of urothelial bladder cancer Room: Lambda Chairs: J.P.M. Sedelaar, Nijmegen (NL) P. Vaganovs, Riga (LV)

15.30 – 16.10 Progress of current management in advanced urotellial and prostate cancers Chairs: B. Djavan, Vienna (AT) M. Jievaltas, Kaunas (LT) T. Tamm, Tallinn (EE)

15.30 – 15.50 Immune check point blockade for bladder cancer – where are we? M-O. Grimm, Jena (DE) 15.50 – 16.10 mCRPC resistance to androgen signalling targeting drugs: Prediction and

overcoming T. Visakorpi, Tampere (FI)

16.10 – 16.25 Awards for Best Poster Presentation and Young Urologist Competition

16.25 – 16.30 Closing remarks and farewell



ESU/ ESUT Hands-on Training courses in Laparoscopy

Course Coordinator: J. Klein, Ulm (DE)

Format: Introduction by course coordinator (15 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (25 minutes)

Room: Gamma/Eta room



14.30 – 15.30 Course 2 Case discussions, Tips & Tricks and Experience exchange Tutors: J. Klein, Ulm (DE) J. Sabalys, Vilnius (LT)

Course 3 focusses on the technical aspects of interesting clinical cases. Two expert surgeons discuss 1-2 prepared cases, each that show a difficult situation that occurs during surgery (e.g. management of bleeding of the renal pedicle during lap. nephrectomy) and how to manage this situation. The cases are prepared by the tutors of the course and discussed with the participants of the course in an interactive way. Furthermore special tips & tricks are shown and/or discussed by the tutors. This leads to an experience exchange that is beneficial for every participant of the course.

You can register for these courses at the EAU registration desk!

Aims and objectivesLaparoscopic procedures are continuously evolving in urology based on the increasing expertise of urologic surgeons. This includes ablative procedures, such as radical nephrectomy as well as reconstructive techniques, such as pyeloplasty. Some advanced procedures (i.e. radical prostatectomy, radical cystectomy) have both, ablative and reconstructive steps. Since the number of centres with laparoscopic expertise is still limited in Europe, laparoscopic training programmes have become very important. Hands-on training courses at the pelvi-trainer represent one of the main steps of such courses. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks.

926-27 May 2017

Poster session 1

Friday, 26 May 2017

11.15 - 12.30 Diagnosis and management of kidney cancer Chairs: D. Milonas, Kaunas (LT) A. Volpe, Novara (IT)Room: Lambda

1 Results of surgery in patients with urological malignancies and tumor thrombus in the right atriumU. Andrushchuk, S. Polyakov, A. Rolevich, Y. Ostrovsky, V. Zharkov (Minsk, Belarus)

2 Acute kidney injury after partial nephrectomy for renal masses in the solitary kidneyL. Suslov, O. Sukonko, S. Krasny, S. Polyakov, A. Minich, A. Rolevich (Minsk, Belarus)

3 Renal cell carcinoma trends in Latvia during 2000-2015: Incidence and survival ratesM. Jakubovskis, U. Kojalo, J Auzinš, A. Belovs, I. Vaivode, S. Pildava, V. Lietuvietis (Riga, Latvia)

4 Impact of positive surgical margins after kidney nephron sparing surgery on clinical disease progression - a single centre experience at long-term follow-upD. Milonas, E. Vaitiekunas, M. Jievaltas (Kaunas, Lithuania)

5 First clinical experience in microwave ablation of kidney lesionsJ. Makevicius, J. Purvaneckas, G. Kucinskis, A. Zelvys, M. Miglinas, F. Jankevicius (Vilnius, Lithuania)

6 Components of metabolic syndrome and prognosis of renal cell cancerT. Eskelinen, A. Kotsar, T.L.J. Tammela, T.J. Murtola (Tampere, Finland; Tartu, Estonia)

7 Withdrawn8 Open and laparoscopic partial nephrectomy: Indications and features

V. Chernylovskyi, S. Styopushkin, V. Chaikovskyi, R. Sokolenko (Dnipropetrovsk, Ukraine)9 Clinical assessment of ERAS protocol for nephron sparing surgery

A. Nosov, M. Berkut, S. Reva, P. Lushina, S. Petrov (Saint-Petersburg, Russia)10 Promoter hypermethylation of tumor suppressor genes in renal cell carcinoma

R. Kubiliute, K. Daniunaite, A. Žalimas, F. Jankevicius, S. Jarmalaite (Vilnius, Lithuania)11 Veriset as a new haemostatic patch; preliminary results in partial nephrectomy

W. Van Der Sanden, L. Fossion (Veldhoven, The Netherlands)12 Our experience in simple enucleation of T1b renal tumors without the use of ischemia

C. Fragkoulis, K. Stasinopoulos, A. Pappas, G. Papadopoulos, G. Stathouros, A. Fragkoulis, I. Gkialas, K. Ntoumas (Athens, Greece)

13 Laparoscopic partial nephrectomy of the horseshoe kidney: Case reportD. Prokhorov, M. Rodina, O. Bogomolov, I. Shevcov, M. Shkolnik (Saint-Petersburg, Russia)

14 Partial nephrectomy of horseshoe kidney with renal cell carcinoma localized in the isthmus and the lower poles of both parts: A case report

V. Grygorenko, V. Zakordonets, R. Danylets, V. Torak, O. Banas, M. Vikarchuk (Kyiv, Ukraine)15 Comparison of patient outcomes between nephron-sparing surgery and radical nephrectomy in 4 to 7 cm renal cell

carcinoma treatmentT. Bruzgelevicius, A. Patasius, A. Ulys (Vilnius, Lithuania)

16 Surgical benefits for patients with metastatic kidney cancer compared with target therapy and prognostic factors role to decide treatment tactic

A. Matulevicius, F. Jankevicius, A. Ulys, A. Patašius (Vilnius, Lithuania)17 Trends in incidence and mortality of kidney cancer in Lithuania in 1993-2012

A. Patasius, A. Ulyte, A. Ulys, G. Smailyte (Vilnius, Lithuania)


Poster session 2

Friday, 26 May 2017

11.15 - 12.30 Miscellaneous Chairs: B. Djavan, Vienna (AT) T. Tamm, Tallinn (EE)Room: Theta

18 Laparoscopic adrenalectomy: Analysis of perioperative eventsA. Minich, M. Panteleev, A. Ryndzin, A. Volkov, A. Rolevich, S. Polyakov (Minsk, Belarus)

19 First results of simultaneous kidney-pancreas transplantations in EstoniaP. Veskimäe, M. Murruste, A. Kotsar, J. Kahu (Tartu, Estonia)

20 Can CROES nephrolithometric nomogram predict postoperative outcomes of percutaneous nephrolithotomy?E. Akdeniz, M.S. Bolat (Samsun, Turkey)

21 Evaluation of rs11568476 mutation of SLC13A2 Gene in IndividualswithHypocitraturiaandCalcium-ContainingKidneyCalculiE. Basaran, A. Tekin, D. Baba, A. Yuksel, Y. Senoglu, S. Duzenli, A. Kayikci (Duzce, Izmir, Bolu, Turkey)

22 Does previous SWL affects the outcomes of retrograde intrarenal surgery outcomes for renal pelvis stones between 1-2 cm?S. Bagbanci, M. Dadali, Y. Dadali, L. Emir, S. Cetinkaya, A. Karabulut (Kirsehir, Turkey)

23 Influence of chemical urinary stone composition on treatment method choiceJ. Purvaneckas, R. Kavaliauskaite, A. Želvys (Vilnius, Lithuania)

24 Quality of life with indwelling ureteral stent. Single clinical center experienceA. Grybas, A. Jaskevicius, E. Starolis (Vilnius, Lithuania)

25 Endoscopic transvesical adenomectomy of the prostate (ETAP), a new minimal invasive treatment for large BPH. A description of the technique and the results of the first 40 patientsW. Van Der Sanden, L. Fossion (Veldhoven, The Netherlands)

26 Extracorporeal magnetic therapy for the treatment of chronic prostatitisA. Gavrusev, A. Strotsky, D. Malashchitsky (Minsk, Belarus)

27 Morphological changes of urethral skeletal muscle in stress urinary incontinenceO. Iatsyna, S. Vernigorodsky, K. Yalovenko (Kiev, Vinnytsa, Ukraine)

28 May the length of the surgical midurethra be longer than the anatomical midurethra? A prospective analysis of the mesh position with translabial ultrasonography in successful cases after transobturator tape operationS. Bagbanci, Y. Dadali, M. Dadali, S. Cetinkaya, A. Karabulut, L. Emir (Kirsehir, Turkey)

29 Withdrawn30 Stem cells prevent graft rejection in tissue engineered urinary bladder

M. Pokrywczynska, M. Rasmus, K. Warda, L. Buchholz, D. Balcerczyk, A. Jundzill, T. Drewa (Bydgoszcz, Poland)31 Genitourinary fistulas: Etiology, diagnostics, prevention

A. Rahuzin, A. Strotsky, D. Malashchitsky, T. Papova (Minsk, Belarus)32 Priapism: The rise and fall of ancient remedies

B. Lau, M. Vithayathil, L. Whittingham (London, United Kingdom)33 Impact of anxiety on erectile dysfunction after transrectal ultrasound guided prostate biopsy

S. Aykan, E. Ates, O. Kose, H. Gulmez, M. Yilmaz, S. Gonultas, I. Ulus, Y. Akin, A.Y. Muslumanoglu (Istanbul, Aydin, Izmir, Konya, Turkey)

34 Increasing amount of perirenal visceral adipose tissue is associated with erectile dysfunctionV. Bondarenko, S. Pimanov (Vitebsk, Belarus)

1126-27 May 2017

Poster session 3

Friday, 26 May 2017

17.00 - 18.15 Advances in diagnosis and management of prostate cancer Chairs: M. Jievaltas, Kaunas (LT) S. Joniau, Leuven (BE)Room: Lambda

35 Therapeutic effect of extent of pelvic lymph node dissection at radical prostatectomy on cancer related outcomesD. Milonas, Z. Venclovas, S. Auskalnis, M. Jievaltas (Kaunas, Lithuania)

36 Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients after radical prostatectomy – a single centre experienceD. Milonas, A. Opolskis, L. Jarusevicius, M. Jievaltas (Kaunas, Lithuania)

37 DNA methylation biomarkers as noninvasive tools for prediction of treatment response in castration -resistant prostate cancerK. Daniunaite, A. Bakavicius, J. Lazutka, A. Ulys, F. Jankevicius, S. Jarmalaite (Vilnius, Lithuania)

38 Salvage radiation therapy following radical prostatectomy. First results of a multicenter Lithuanian studyM. Kincius, M. Jievaltas, B. Šikšniute, A. Opolskis, A. Ulys, F. Jankevicius, D. Milonas (Vilnius, Kaunas, Lithuania)

39 Diagnostic accuracy of transrectal ultrasound and multiparametric MRI after primary negative prostate biopsyA. Karman, S. Shymanets, S. Kharuzhyk, A. Minich, A. Rolevich, S. Krasny (Minsk, Belarus)

40 Study on clinicopathological and genetical factors associated with biochemical recurrence of prostate cancer after radical prostatectomyA. Ladukas, M. Kincius, A. Stumbryte, A. Ulys, G. Smailyte, Z. Gudleviciene (Vilnius, Lithuania)

41 Active surveillance for low-risk prostate cancer: 5-year experience of a single centre prospective studyM. Žarkovski, O. Zahharova, A. Kotsar (Tartu, Estonia)

42 Multiparametric MRI followed by transperineal template-guided mapping biopsy for detection of prostate cancer in patients after initial negative transrectal ultrasound-guided biopsyA. Veželis, M. Kincius, A. Ulys, D. Petroška, S. Jarmalaite, R Briediene, I. Naruševiciute, F. Jankevicius (Vilnius, Lithuania)

43 The role of pathomorphological findings in prognosis of clinically locally advanced prostate cancer after radical prostatectomyV. Grygorenko, M. Vikarchuk, R. Danylets, S. Volkov, N. Brovko, O. Banas (Kyiv, Ukraine)

44 Down-regulation of miR-149 in TMPRSS2-ERG gene fusion-positive prostate cancerR. Sabaliauskaite, K. Stuopelyte, F. Jankevicius, T. Visakorpi, S. Jarmalaite (Vilnius, Lithuania; Tampere, Finland)

45 Comparison of oncological outcomes after radical prostatectomy in patients with clinically locally advanced and high risk localized prostate cancerS.O. Vozianov, V.M. Grygorenko, M.V. Vikarchuk, R.O. Danylets, N.V. Brovko, O.O. Banas (Kyiv, Ukraine)

46 Stereotactic ablative radiosurgery for treatment of primary prostate cancer and oligometastatic disease: Diagnostic and treatment delivery considerationsM. Mezeckis, V. Buryk, D. Saukuma, M. Skromanis (Sigulda, Latvia)

47 Quality of life and oncological outcomes 4 years after salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy in Lithuania (National Cancer Institute data)Z. Kardelis, K. Ulinskas, E. Janulionis, A. Ulys (Vilnius, Lithuania)

48 Survival in patients with locally advanced prostate cancer: A population-based studyS. Polyakov, A. Yaumenenka (Minsk, Belarus)

49 Association of prostate specific antigen with blood cell counts at different time points of metastatic prostate cancer evolutionM. Kase, K. Ojamaa, M. Vardja, S. Kase, I. Zahharova, J. Jaal, J. Jaal (Tallinn, Tartu, Estonia; Riga, Latvia)

50 68Ga-PSMA ligand PET/CT in patients with prostate cancer: First experienceA. Freimanis, V. Lietuvietis, V. Skrivelis (Riga, Latvia)

51 Prostate cancer incidence, mortality and survival trends in Estonia 1995–2014K. Innos, A. Baburin, A. Kotsar, I-E. Eiche, K. Lang (Tallinn, Tartu, Estonia)


Poster session 4

Friday, 26 May 2017

17.00 - 18.15 Miscellaneous Chairs: H. Hashim, Bristol (GB) A. Kotsar, Tartu (EE)Room: Theta

52 Overactive bladder is associated with channelopathy of potassium channelsO. Iatsyna, A. Sapsai, O. Parshikov, A. Soloviev, F. Kostev, K. Yalovenko (Kyiv, Odessa, Ukraine)

53 Histomorphology of interstitial cells of Cajal and smooth muscle cells in a new rat model of overactive bladderO. Iatsyna, S. Vernigorodsky, K. Yalovenko (Kyiv, Vinnitsa, Ukraine)

54 Fibroblast growth factor modulate expression of galanin in dorsal root ganglia neurons supplying urinary bladder of the pig: An in vitro studyA. Kozlowska, A. Mikołajczyk, L. Klimaschewski, M. Majewski (Olsztyn, Poland; Innsbruck, Austria)

55 Changes in calcitonin gene-related peptide expression induced by neurotrophin-3 in cultured dorsal root ganglia (DRG) neurons supplying urinary bladder of the pigA. Kozlowska, A. Mikołajczyk, L. Klimaschewski, M. Majewski (Olsztyn, Poland; Innsbruck, Austria)

56 Comparison of guanethidine-, botulinum toxin- and resiniferatoxin-induced changes in the chemical coding of dorsal root ganglia neurons supplying the porcine urinary bladderA. Bossowska, P. Janikiewicz, E. Lepiarczyk, U. Mazur, M. Majewski (Olsztyn, Poland)

57 Neurochemical characterization of phoenixin-containing inferior mesenteric ganglion (IMG) sympathetic neurons innervating porcine urinary bladder in intact and botulinum toxin-treated animals – a preliminary studyP. Janikiewicz, B. Bartos, J. Czesak, A. Bossowska, M. Majewski (Olsztyn, Poland)

58 Isoproteronol-mediated relaxation of carbachol-pre-contracted mouse detrusor smooth muscleM.H. Tanyeri, M.E. Buyukokuroglu, P. Tanyeri, O. Mutlu, F. Akar, G. Ulak, B.F. Erden (Sakarya, Kocaeli, Turkey)

59 Chronic effect of atypical antipsychotic drug blonanserine on vas deferens contraction in miceM.H. Tanyeri, M.E. Buyukokuroglu, P. Tanyeri, O. Mutlu, F. Akar, G. Ulak, B.F. Erden (Sakarya, Kocaeli, Turkey)

60 Epidemiology of testicular cancer in the Republic of Belarus and trends in cause-specific survivalA. Yaumenenka, A. Rolevich, A. Minich, A. Okeanov, S. Polyakov (Minsk region, Belarus)

61 12 months patency of tunneled hemodialysis catheter using two different insertion techniquesG. Sakalauskaite, A. Rimkus, R. Kripaityte, R. Tyla, M. Miglinas (Vilnius, Lithuania)

62 Effect of urine on cell line in vitro: Implication for urinary tract regenerationT. Kloskowski, M. Pokrywczynska, D. Balcerczyk, M. Buhl, A. Jundzill, M. Nowacki, T. Drewa (Bydgoszcz, Poland)

63 Analysis of clonal, proliferative and self-renewing potential of porcine urothelial cells in in vitro cultureM. Buhl, M. Pokrywczynska, M. Gagat, A. Jundziłł, D. Balcerczyk, K. Warda, M. Rasmus, A. Grzanka, T. Drewa (Bydgoszcz, Poland)

64 Isolation and culture of human adipose derived stem cells for clinical application in urologyK. Warda, M. Pokrywczynska, T. Kloskowski, D. Balcerczyk, M. Rasmus, M. Buhl, A. Jundzill, T. Drewa (Bydgoszcz, Poland)

65 Adipose derived stem cell properties in long-term culture- an implications for regenerative medicineM. Rasmus, M. Maj, D. Balcerczyk, M. Buhl, K. Warda, A. Jundzill, L. Buchholz, T. Kloskowski, M. Pokrywczynska, T. Drewa (Bydgoszcz, Poland)

66 Is a one-day hospital stay after percutaneous nephrolithotomy safe? Clinical experience in the evaluation of 30 patientsM. Kuskowski, R. Liss, K. Kodrycki, M. Przudzik, M. Roslan (Olsztyn, Poland)

67 Urinary bladder diverticulum imitating BOOR. Ots, P. Veskimäe, J. Idavain, A. Kotsar (Tartu, Estonia)

1326-27 May 2017

Poster session 5

Saturday, 27 May 2017

14.15 - 15.30 Advances in the management of urothelial bladder cancer Chairs: J.P.M. Sedelaar, Nijmegen (NL) P. Vaganovs, Riga (LV)Room: Lambda

68 5α-reductase inhibitors use and bladder cancer-specific mortality in a Finnish population-based cohortV. Mäkelä, A. Kotsar, T.L.J. Tammela, T.J. Murtola (Tampere, Finland; Tartu, Estonia)

69 The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomyS. Gorgel, O. Kose, E.M. Koc, E. Ates, Y. Akin, Y. Yilmaz (Izmir, Turkey)

70 Withdrawn71 Simple model predicting 90-day mortality after radical cystectomy

A. Ryndzin, L.A. Zaitseva, A.A. Rolevich, S.A. Krasny (Minsk, Belarus)72 Long-term benefit of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder

cancer is dependent on quality of surgeryA. Rolevich, A. Minich, A. Zhegalik, A. Mokhort, V. Vasilevich, T. Nabebina, S. Krasny, S. Polyakov (Minsk, Belarus)

73 Radical cystectomy in patients aged ≥75 years – analysis of complicationsK. Kaczmarek, A. Leminski, D. Gajewska, A. Bancarz, A. Zakrzewska, J. Lisinski, M. Wojtarowicz, M. Słojewski (Szczecin, Poland)

74 Red patches biopsy and urine cytology during cystocopy: diagnostic tool for bladder malignancy?N. Nabi, D. Silviu, B. Mark, L. Aisling, E. Samah, N. Sarah, M. Akram, N. Girish, S. Giri (Limerick, Ireland)

75 The use of a stapling device in the transecting the vascular pedicle in laparoscopic radical cystectomyW. Van Der Sanden, L. Fossion (Veldhoven, The Netherlands)

76 Reduction of intensive care admission thanks to laparoscopic approach for radical cystectomyF. Rasenberg, W. Van Der Sanden, L. Fossion (Veldhoven, The Netherlands)

77 (R)evolution from open to laparoscopic radical cystectomy as golden standardL. Fossion, B-M. De Ruiter, W. Van Der Sanden, N. Kil, T. Hermans (Veldhoven, The Netherlands)

78 Immunohistochemical expression of c-Myc in patients with urinary bladder transitional cell carcinoma and correlation with tumor grade, stage and lymph node metastasisC. Fragkoulis, K. Stasinopoulos, A. Kostopoulou, G. Papadopoulos, G. Stathouros, T. Choreftaki, K. Ntoumas (Athens, Greece)

79 Gender-related differences in bladder cancer at the time of diagnosisD. Gajewska, K. Kaczmarek, A. Leminski, M. Słojewski (Szczecin, Poland)

80 Early mortality after radical cystectomy in PolandK. Kaczmarek, A. Leminski, D. Gajewska, J. Lisinski, M. Wojtarowicz, M. Słojewski (Szczecin, Poland)

81 One Stop Haematuria Clinic – how do we assess?A. Bhuvanagiri, S. Kannan, H. Lock, D. Thomas, E. May, K. Alexandrou, E. Ahiaku, W. Walker (Bangor, United Kingdom)

82 Primary malignant melanoma of the urethra and complex treatmentM. Berkut, S. Reva, A. Nosov, S. Petrov (Saint-Petersburg, Russia)


Do not missthe AwardSession!Prestigious awards for Best Poster Presentations and Young Urologist Competitors will be handed out on the last day of the meeting

• The awards will be presented at the end of the meeting by Prof. Mindaugas Jievaltas and Dr. Michiel Sedelaar

• The award winners will be selected on-site by the chairmen of the poster sessions.

• The award-winning posters will be displayed in a specifically designated area at the Annual EAU Congress

• The award winners will be invited to present their poster at the 33rd Annual EAU congress in Copenhagen, 16-20 March 2018

Industry sponsored

Saturday, 27 May 201716.10 hrsPlenary Room (Alfa room)

INVITATIONJanssen Satellite Symposium at the

4th EAU Baltic Meeting

Future insights in metastatic Prostate Cancer

VenueRadisson Blu hotel Lietuva

26th May 2017 14:15 – 15.00

Moderated by Prof. Mindaugas Jievaltas (LT)

Welcome and IntroductionProf. Mindaugas Jievaltas

Advances in metastatic prostate cancer imagingProf. Ilona Kulakienė (LT)

Future insights in metastatic prostate cancerProf. Kurt Miller MD, PhD (DE)

Q&A (All)

PHLT/ZYT/0517/0001

Sponsored symposium (Berlin-Chemie)

Saturday, 27 May 2017, 12.15 – 13.15

SEXUAL FUNCTION AND BPH TREATMENT

+ CASE DISCUSSION

Chair: Prof. B. Djavan (Vienna, A)

12:15 Sexual function and BPH treatment Prof. B. Djavan (Vienna, A)

followed by

Case discussion PE patient – case discussion: Greta Peciulyte (Kaunas, LT) ED patient – case discussion: Pauls Stradins (Riga, LV)

Venue of the Meeting: Radisson Blu Hotel Lietuva Konstitucijos 20, LT–09308 Vilnius

4th Baltic Meeting in conjunction with the Vilnius, Lithuania 26.– 27. May 2017

The EAU is very grateful for the support of thefollowing contributors:

MAIN SPONSORS

SPONSORS

Contributors

1926-27 May 2017

Cutting-edge Science at Europe’s largest Urology Congress

33rd Annual EAU Congress

www.eau18.org

baltic17 - lud€¦ · furthermore special tips & tricks are shown and/or discussed by the...

Documents